Department of Cardiology and Institute of Vascular Medicine, Peking University Third Hospital, NHC Key Laboratory of Cardiovascular Molecular Biology and Regulatory Peptides, Key Laboratory of Molecular Cardiovascular Science, Ministry of Education, Beijing Key Laboratory of Cardiovascular Receptors Research, Beijing, China.
Department of Cardiology, Guangzhou Red Cross Hospital, Medical College, Jinan University, Guangzhou, China.
Adv Exp Med Biol. 2022;1377:109-118. doi: 10.1007/978-981-19-1592-5_8.
In this chapter, we summarize the relationship between circulating high-density lipoprotein (HDL) and atherosclerotic cardiovascular disease (ASCVD). HDL acts in many types of cells, such as endothelial cell, macrophage, T lymphocyte, etc. Recently, novel HDL-related therapies have been developed to treat ASCVD.
在这一章中,我们总结了循环高密度脂蛋白(HDL)与动脉粥样硬化性心血管疾病(ASCVD)之间的关系。HDL 作用于多种类型的细胞,如内皮细胞、巨噬细胞、T 淋巴细胞等。最近,开发了新型的与 HDL 相关的治疗方法来治疗 ASCVD。